FDA Warning Wire: New Woes For Wockhardt
By Jeff Overley ( January 19, 2016, 6:37 PM EST) -- Beleaguered Indian drugmaker Wockhardt leads this week's look at U.S. Food and Drug Administration enforcement actions after inspectors criticized numerous issues at a new manufacturing plant. FDA officials also complained about a medical device maker's promotional claims and a compounding pharmacy's decision to let dogs hang out near its laboratory....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.